Soonhak Kwon
Biographic Data
| ID | 7957028 |
|---|---|
| NAME | Soonhak Kwon |
| GIVEN NAMES | Soonhak |
| FAMILY NAME | Kwon |
| SIGNATURE | KWON S |
| AFFILIATIONS | Kyungpook National University Hospital |
| ORCID | 0000-0002-0783-2243 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Episodic Ataxia Type 2 Presenting with Fluctuating Weakness in a Child with a De Novo Cacna1A Variant
Background: Episodic ataxia type 2 (EA2) is the most common subtype of episodic ataxia and is primarily caused by pathogenic variants in the CACNA1A gene. Although classically characterized by paroxysmal ataxia, CACNA1A-related disorders are increasingly recognized as an age-dependent phenotypic continuum that extends beyond episodic cerebellar dysfunction to include fluctuating weakness, persistent neurological signs, and neurodevelopmental impa…
Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients
Background: Potential adverse effects might be caused by increasing the number of antipsychotic prescriptions. However, the empirical evidence regarding pediatric psychiatric patients is insufficient. Therefore, we explored the antipsychotic-induced adverse effects focusing on the neurological system. Method: Using the medical information of pediatric patients retrieved from the claims data of Health Insurance Review and Assessment in Korea, we i…
No prominent works on this page.
Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients
Background: Potential adverse effects might be caused by increasing the number of antipsychotic prescriptions. However, the empirical evidence regarding pediatric psychiatric patients is insufficient. Therefore, we explored the antipsychotic-induced adverse effects focusing on the neurological system. Method: Using the medical information of pediatric patients retrieved from the claims data of Health Insurance Review and Assessment in Korea, we i…
Episodic Ataxia Type 2 Presenting with Fluctuating Weakness in a Child with a De Novo Cacna1A Variant
Background: Episodic ataxia type 2 (EA2) is the most common subtype of episodic ataxia and is primarily caused by pathogenic variants in the CACNA1A gene. Although classically characterized by paroxysmal ataxia, CACNA1A-related disorders are increasingly recognized as an age-dependent phenotypic continuum that extends beyond episodic cerebellar dysfunction to include fluctuating weakness, persistent neurological signs, and neurodevelopmental impa…
Adverse effect (1 work) · Antipsychotic (1 work) · Ataxia (1 work) · Cardiac electrophysiology and arrhythmias (1 work) · Cerebellar ataxia (1 work) · Channelopathy (1 work) · Epilepsy research and treatment (1 work) · Genetic Neurodegenerative Diseases (1 work) · Genomics and Rare Diseases (1 work) · Global developmental delay (1 work)